Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to BioSensics LLC in August, 2020 for $450,002.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AG067909-01 | Phase I | 450,002 | August 1, 2020 | |||||||
A SBIR Phase II contract was awarded to BioSensics LLC in February, 2020 for $818,052.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44GM123821-02 | Phase II | 818,052 | February 1, 2020 | |||||||
A STTR Phase II contract was awarded to BioSensics LLC in September, 2019 for $1,999,992.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 4R42AG060853-02 | Phase II | 1,999,992 | September 1, 2019 | |||||||
A SBIR Phase II contract was awarded to BioSensics LLC in June, 2018 for $2,387,054.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2SB1AG032748-06 | Phase II | 2,387,054 | June 1, 2018 | |||||||
A STTR Phase I contract was awarded to BioSensics LLC in April, 2018 for $402,769.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41AG058295-01A1 | Phase I | 402,769 | April 15, 2018 | |||||||
A STTR Phase I contract was awarded to BioSensics LLC in September, 2018 for $350,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R42AG060853-01 | Phase I | 350,000 | September 1, 2018 | |||||||
A SBIR Phase I contract was awarded to BioSensics LLC in July, 2020 for $348,832.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DA049622-01 | Phase I | 348,832 | July 1, 2020 | |||||||
A SBIR Phase II contract was awarded to BioSensics LLC in September, 2021 for $1,250,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AG061951-02 | Phase II | 1,250,000 | September 1, 2021 | |||||||
A SBIR Phase I contract was awarded to BioSensics LLC in September, 2020 for $256,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA254835-01A1 | Phase I | 256,000 | September 14, 2020 | |||||||
A SBIR Phase I contract was awarded to BioSensics LLC in June, 2020 for $450,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AG066360-01A1 | Phase I | 450,000 | June 15, 2020 | |||||||
A STTR Phase I contract was awarded to BioSensics LLC in September, 2018 for $412,281.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41AG061951-01 | Phase I | 412,281 | September 30, 2018 | |||||||
A SBIR Phase II contract was awarded to BioSensics LLC in September, 2019 for $1,490,863.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AG065014-01 | Phase II | 1,490,863 | September 15, 2019 | |||||||
A SBIR Phase II contract was awarded to BioSensics LLC in June, 2022 for $1,246,336.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AG067909-02 | Phase II | 1,246,336 | June 15, 2022 | |||||||
A SBIR Phase II contract was awarded to BioSensics LLC in September, 2022 for $1,250,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AG080861-01 | Phase II | 1,250,000 | September 30, 2022 | |||||||
A SBIR Phase I contract was awarded to BioSensics LLC in September, 2022 for $500,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44NS122672-01A1 | Phase I | 500,000 | September 15, 2022 | |||||||
A STTR Phase I contract was awarded to BioSensics LLC in September, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R42AG059491-01 | Phase I | 225,000 | September 15, 2018 | |||||||
A SBIR Phase II contract was awarded to BioSensics LLC in June, 2021 for $1,230,172.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AG066360-02 | Phase II | 1,230,172 | June 1, 2021 | |||||||
A STTR Phase II contract was awarded to BioSensics LLC in September, 2019 for $1,039,094.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 4R42AG059491-02 | Phase II | 1,039,094 | September 15, 2019 | |||||||
A SBIR Phase II contract was awarded to BioSensics LLC in September, 2022 for $1,008,134.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44HD084035-04 | Phase II | 1,008,134 | September 19, 2022 | |||||||
A SBIR Phase I contract was awarded to BioSensics LLC for $325,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N95022C00040 | Phase I | 325,000 | ||||||||
A SBIR Phase II contract was awarded to BioSensics LLC in April, 2016 for $750,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AR069421-01 | Phase II | 750,000 | April 1, 2016 | |||||||
A SBIR Phase II contract was awarded to BioSensics LLC in September, 2015 for $1,500,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AG051374-01 | Phase II | 1,500,000 | September 30, 2015 | |||||||
A SBIR Phase I contract was awarded to BioSensics LLC in August, 2017 for $500,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM123821-01 | Phase I | 500,000 | August 11, 2017 | |||||||
A SBIR Phase I contract was awarded to BioSensics LLC in September, 2015 for $225,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44HD084035-01A1 | Phase I | 225,000 | September 8, 2015 | |||||||
A SBIR Phase II contract was awarded to BioSensics LLC in June, 2015 for $1,455,491.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AG050338-01 | Phase II | 1,455,491 | June 15, 2015 |